InvestorsHub Logo
Followers 4
Posts 365
Boards Moderated 0
Alias Born 04/20/2020

Re: Badge04 post# 125981

Saturday, 10/24/2020 3:47:38 PM

Saturday, October 24, 2020 3:47:38 PM

Post# of 232916
News from the FDA in February 2020. Efficasy of Leronlimab 81 % with 350 mg.

Approval July 2020.

Suddenly end of July 2020, change of status improvement, new studies of 500 patients on test of mono therapy, also, FDA wants occupancy teat for patience on dose of 700mg and another test for receptor on occupansy on the
750 mg.

What the FDA wanted with the new test was to stop the approval of Leronlimab.

What you describe here in your article is true and is the continuancy of the July 2020 change of statue improvement, that was not necessary with that perfect medication like Leronlimab.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News